Anil K Agarwal

Summary

Country: USA

Publications

  1. ncbi Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly
    Anil K Agarwal
    The Ohio State University, Internal Medicine, Division of Nephrology, Columbus, OH 43210, USA
    J Am Med Dir Assoc 7:S7-S12; quiz S17-21. 2006
  2. ncbi Central vein stenosis: a nephrologist's perspective
    Anil K Agarwal
    Division of Nephrology, Department of Internal Medicine, Ohio State University, Columbus, Ohio 43210, USA
    Semin Dial 20:53-62. 2007
  3. doi Central vein stenosis: current concepts
    Anil K Agarwal
    Division of Nephrology, The Ohio State University, Columbus, OH 43210, USA
    Adv Chronic Kidney Dis 16:360-70. 2009
  4. pmc Anemia associated with chronic heart failure: current concepts
    Ravish Shah
    Division of Nephrology, The Ohio State University, Columbus, Ohio 43210, USA
    Clin Interv Aging 8:111-22. 2013
  5. ncbi Drug safety profile of darbepoetin alfa for anemia of chronic kidney disease
    Anil K Agarwal
    The Ohio State University, 395 W 12th Avenue, Columbus, Ohio 43210, USA
    Expert Opin Drug Saf 8:145-53. 2009
  6. doi Central vein stenosis
    Anil K Agarwal
    Interventional Nephrology, The Ohio State University, Columbus, OH 43210, USA
    Am J Kidney Dis 61:1001-15. 2013
  7. ncbi Pumping iron: revisiting risks, benefits and strategies in treatment of iron deficiency in end-stage renal disease
    Neeraj Singh
    Division of Nephrology, The Ohio State University, Columbus, OH 43210, USA
    Clin Nephrol 77:188-94. 2012
  8. doi Iatrogenic graft to vein fistula (GVF) formation associated with synthetic arteriovenous grafts
    Nabil J Haddad
    The Ohio State University, Columbus, Ohio Dialysis Access Group of Wake Forest University, Winston Salem, North Carolina 43210, USA
    Semin Dial 23:643-7. 2010
  9. doi Catheter outcomes in the short-term inpatient setting: a controlled quality improvement study comparing citrate and heparin lock
    Samir Parikh
    Department of Internal Medicine, The Ohio State University, Columbus, OH, USA
    Semin Dial 25:351-6. 2012
  10. ncbi Hemodialysis access monitoring and surveillance, how and why?
    Nabil J Haddad
    Department of Medicine, Nephrology Division, The Ohio State University Medical Center, Columbus, Ohio 43210, USA
    Front Biosci (Elite Ed) 4:2396-401. 2012

Collaborators

Detail Information

Publications20

  1. ncbi Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly
    Anil K Agarwal
    The Ohio State University, Internal Medicine, Division of Nephrology, Columbus, OH 43210, USA
    J Am Med Dir Assoc 7:S7-S12; quiz S17-21. 2006
    ..Poor response to treatment with ESP can be due to many factors, including presence of iron deficiency, inflammation, continued blood loss, and hemoglobinopathy...
  2. ncbi Central vein stenosis: a nephrologist's perspective
    Anil K Agarwal
    Division of Nephrology, Department of Internal Medicine, Ohio State University, Columbus, Ohio 43210, USA
    Semin Dial 20:53-62. 2007
    ....
  3. doi Central vein stenosis: current concepts
    Anil K Agarwal
    Division of Nephrology, The Ohio State University, Columbus, OH 43210, USA
    Adv Chronic Kidney Dis 16:360-70. 2009
    ..Early referral of the patients to the nephrologists by the primary care physicians is important. Timely vein mapping and referral to the surgeon for fistula creation can obviate the need for a CVC and decrease incidence of CVS...
  4. pmc Anemia associated with chronic heart failure: current concepts
    Ravish Shah
    Division of Nephrology, The Ohio State University, Columbus, Ohio 43210, USA
    Clin Interv Aging 8:111-22. 2013
    ..Available and emerging new agents in the treatment of anemia of heart failure will need to be tested in randomized, controlled studies...
  5. ncbi Drug safety profile of darbepoetin alfa for anemia of chronic kidney disease
    Anil K Agarwal
    The Ohio State University, 395 W 12th Avenue, Columbus, Ohio 43210, USA
    Expert Opin Drug Saf 8:145-53. 2009
    ..Strategies to achieve and maintain a reasonable, individualized target hemoglobin level with minimal variations in hemoglobin level are needed...
  6. doi Central vein stenosis
    Anil K Agarwal
    Interventional Nephrology, The Ohio State University, Columbus, OH 43210, USA
    Am J Kidney Dis 61:1001-15. 2013
    ....
  7. ncbi Pumping iron: revisiting risks, benefits and strategies in treatment of iron deficiency in end-stage renal disease
    Neeraj Singh
    Division of Nephrology, The Ohio State University, Columbus, OH 43210, USA
    Clin Nephrol 77:188-94. 2012
    ..In this review, we discuss the benefits and risks associated with i.v. iron and the practical aspects of iron administration that can minimize the complications related to iron therapy in ESRD...
  8. doi Iatrogenic graft to vein fistula (GVF) formation associated with synthetic arteriovenous grafts
    Nabil J Haddad
    The Ohio State University, Columbus, Ohio Dialysis Access Group of Wake Forest University, Winston Salem, North Carolina 43210, USA
    Semin Dial 23:643-7. 2010
    ..We report a series of eight cases with GVF formation between AVG and adjacent veins. Awareness of this complication and intervention to relieve stenotic lesions may result in improved AVG survival...
  9. doi Catheter outcomes in the short-term inpatient setting: a controlled quality improvement study comparing citrate and heparin lock
    Samir Parikh
    Department of Internal Medicine, The Ohio State University, Columbus, OH, USA
    Semin Dial 25:351-6. 2012
    ..Catheter lock with 2.2% ACD has lower risk of catheter dysfunction as compared with that of 5000 U/ml heparin in the short-term inpatient setting in NTDC and similar risk in TDC...
  10. ncbi Hemodialysis access monitoring and surveillance, how and why?
    Nabil J Haddad
    Department of Medicine, Nephrology Division, The Ohio State University Medical Center, Columbus, Ohio 43210, USA
    Front Biosci (Elite Ed) 4:2396-401. 2012
    ..This review discusses pros and cons of various monitoring and surveillance techniques and suggests a strategy based on current literature...
  11. pmc Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations
    Savitha Shastry
    Division of Nutrition and Metabolic Diseases, Department of Internal Medicine, Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
    Am J Med Genet A 152:2245-53. 2010
    ..It is unclear how mutations in PTRF, which plays an essential role in formation of caveolae, affect a wide variety of tissues resulting in a variable phenotype...
  12. doi Future directions in management of anemia in heart failure
    Anil K Agarwal
    Division of Nephrology, The Ohio State University, 395 West 12th Avenue, Ground Floor, Columbus, OH 43210, USA
    Heart Fail Clin 6:385-95. 2010
    ..Ongoing prospective clinical outcomes studies of ESA and intravenous iron therapies will provide important data that may pave the way for new avenues in the treatment of anemia in the future...
  13. doi Therapy with erythropoiesis-stimulating agents and renal and nonrenal outcomes
    Anil K Agarwal
    Division of Nephrology, The Ohio State University, 395 West 12th Avenue, Ground Floor, Columbus, OH 43210, USA
    Heart Fail Clin 6:323-32. 2010
    ....
  14. pmc PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome
    Anil K Agarwal
    Department of Internal Medicine, Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, 75390, USA
    Am J Hum Genet 87:866-72. 2010
    ..We conclude that mutations in PSMB8 cause JMP syndrome, most probably by affecting MHC class I antigen processing...
  15. pmc A mathematical model of venous neointimal hyperplasia formation
    Paula Budu-Grajdeanu
    Mathematical Biosciences Institute, The Ohio State University, Columbus, OH, USA
    Theor Biol Med Model 5:2. 2008
    ..The release of growth factors due to surgical injury, oxidative stress and turbulent flow has been suggested as a possible mechanism for neointimal hyperplasia...
  16. ncbi Usual ACE inhibitor therapy in CKD patients is associated with lower plasma aldosterone levels than usual angiotensin receptor blocker therapy
    Nabil Haddad
    Department of Internal Medicine, The Ohio State University, Columbus, Ohio 43210, USA
    Kidney Blood Press Res 30:299-305. 2007
    ..This study tested whether ACE inhibitor (I) therapy achieves lower plasma (p) ALDO levels than angiotensin receptor blocker (ARB) therapy when they are used under usual clinical conditions in chronic kidney disease (CKD) patients...
  17. ncbi Teriparatide or alendronate in glucocorticoid-induced osteoporosis
    Uday S Nori
    N Engl J Med 358:1302-3; author reply 1303-4. 2008
  18. doi Management of patients of postcholecystectomy benign biliary stricture complicated by portal hypertension
    Anil K Agarwal
    Department of Gastrointestinal Surgery, Gobind Ballabh Pant Hospital and Maulana Azad Medical College, New Delhi, India
    Am J Surg 195:421-6. 2008
    ..Single-center experience of primary repair without preceding PSS in patients of BBS with PHT and a patent portal vein is presented...
  19. ncbi Diaphragm disease of the ileum: a case report
    As Puri
    Department of Gastroenterology, GB Pant Hospital, New Delhi
    Trop Gastroenterol 27:46-7. 2006
    ..We report the first case of ileal diaphragm disease from Asia. She responded well to localised resection of the diseased ileum. Intra-operative enteroscopy may be helpful in deciding the extent of intestinal resection...
  20. ncbi Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression
    Lee A Hebert
    Am J Kidney Dis 45:788-9; author replyy 789-90. 2005